Home
Conditions
Lung Neoplasms

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,205 public trials 1,002 recruiting studies

Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Active, Not Recruiting

Long-term Outcomes Among Patients With Programmed Death-ligand 1 <1% Metastatic Non-small Cell Lung Cancer Treated With First-line Nivolumab + Ipilimumab + 2 Cycles of Chemotherapy

NCT07024862

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Cardinal Health Dublin, Ohio, United States

View Trial Details

Active, Not Recruiting

Phase 2 Study of Dacomitinib in NSCLC

NCT04027647

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations: Prince of Wales Hospital Hong Kong

Sarawak General Hospital Kuching, Sarawak, Malaysia

University Malaya Medical Centre Kuala Lumpur, Malaysia

Beacon Hospital Petaling Jaya, Malaysia

View Trial Details

Active, Not Recruiting

SBRT Followed by Neoadjuvant Immunochemotherapy in Resectable Stage II to III Non-small Cell Lung Cancer

NCT05319574

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

A Study of BMS-986449 With and Without Nivolumab in Participants With Advanced Solid Tumors

NCT05888831

Conditions: Advanced Solid Tumors, Breast Diseases, Breast Neoplasms, +13 more
Locations: Local Institution - 0021 Los Angeles, California, United States

Local Institution - 0007 New Haven, Connecticut, United States

Local Institution - 0010 Hackensack, New Jersey, United States

Local Institution - 0022 Lake Success, New York, United States

View all 20 locations

View Trial Details

Active, Not Recruiting

A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer

NCT03800134

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +11 more
Locations: Research Site Phoenix, Arizona, United States

Research Site Duarte, California, United States

Research Site Orange, California, United States

Research Site Aurora, Colorado, United States

View all 231 locations

View Trial Details

Active, Not Recruiting

Phase-2 Dacomitinib Study on Patients With EGFR-Driven Advanced Solid Tumours With Low EGFR-AS1 IncRNA Expr or Other Novel Emerging Biomarkers

NCT04946968

Conditions: Advanced Solid Tumours, Bronchial Neoplasms, Carcinoma, +16 more
Locations: National University Cancer Institute, Singapore Singapore

National Cancer Centre Singapore Singapore

View Trial Details

Active, Not Recruiting

Two Schedules of Hyperfractionated Thoracic Radiotherapy in Limited Disease Small Cell Lung Cancer

NCT02041845

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations: Rigshospitalet København Copenhagen, Denmark

Odense University Hospital Odense, Denmark

Ålesund sykehus Ålesund, Norway

Haukeland Universitetssykehus Bergen, Norway

View all 22 locations

View Trial Details

Active, Not Recruiting

Safety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLC

NCT03970746

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Grand Hôpital de Charleroi Charleroi, Belgium

Jessa Ziekenhuis Hasselt, Belgium

AZ Groeninge Kortrijk, Belgium

University Hospitals KU Leuven Leuven, Belgium

View all 16 locations

View Trial Details

Active, Not Recruiting

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

NCT05704985

Conditions: Bronchial Neoplasms, Cancer, Carcinoma, Bronchogenic, +42 more
Locations: City of Hope Duarte, California, United States

Northwell Health Manhasset, New York, United States

OU Health Stephenson Cancer Center Oklahoma City, Oklahoma, United States

Mary Crowley Cancer Research Dallas, Texas, United States

View Trial Details

Active, Not Recruiting

Gene Molecular Alterations as Disease Prognostic Markers in Patients With Non-small Cell Lung Cancer (NSCLC)

NCT06876402

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Hellenic Cooperative Oncology Group (HeCOG) Athens, Greece

View Trial Details

Lung Neoplasms

Lung Neoplasms trial results

Related conditions